[Skip to Content]
[Skip to Content Landing]
July 17, 2002

Transfusion-Related Acute Lung Injury—Reply

Author Affiliations

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthor

JAMA. 2002;288(3):315-316. doi:10.1001/jama.288.3.311

In Reply: The look-back study performed by Dr Cooling provides additional support for the policy of permanent deferral of blood donors who have been directly implicated in a TRALI reaction. The study also supports our conclusion that TRALI is underrecognized and underreported.

Although the incidence of TRALI in the 2 look-back studies was 15% and 36%, this should not be confused with the overall incidence of TRALI. The donors in both look-back studies possessed antibodies to white blood cells. It should not be assumed that the incidence of TRALI reactions from the transfusion of blood components without such antibodies would be similar. Studies examining all cases of acute respiratory distress associated with transfusion, at a single hospital, suggest the rate of TRALI is about 1 per 5000 transfusions or 1 per 2000 patients transfused.1,2 These studies, however, do not include milder forms of TRALI without acute respiratory distress and thus may underestimate the incidence of TRALI.